Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib may help regrow hair in alopecia areata patients.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

CTP-543 is generally safe for treating alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.